176 related articles for article (PubMed ID: 4377553)
21. Humoral and cellular immunity in the anergic tuberculosis patient. A prospective study.
Zeitz SJ; Ostrow JH; Van Arsdel PP
J Allergy Clin Immunol; 1974 Jan; 53(1):20-6. PubMed ID: 4202828
[No Abstract] [Full Text] [Related]
22. Successful renal transplantation in patients with circulating antibody to glomerular basement membrane: report of two cases.
Couser WG; Wallace A; Monaco AP; Lewis EJ
Clin Nephrol; 1973; 1(6):381-8. PubMed ID: 4595000
[No Abstract] [Full Text] [Related]
23. Cytomegalovirus infections in renal transplant recipients. Correlation between clinical disease and results of a specific ELISA.
Metselaar HJ; Rotbarth PH; Kramer P; Bijnen AB; Jeekel J; Masurel N; Weimar W
Antiviral Res; 1985; Suppl 1():127-30. PubMed ID: 3002252
[No Abstract] [Full Text] [Related]
24. Reliability of the changes of serum complement, C3, and immunoglobulins during acute rejection of renal allografts: correlations with clinical severity.
Rodriguez-Iturbe B; Serrano H; García R; Gallegos B
Transplantation; 1971 Nov; 12(5):405-7. PubMed ID: 4114304
[No Abstract] [Full Text] [Related]
25. Oligoclonal banding in serum from heart-transplant recipients.
Monk J; Calvin J; Price CP; Wreghitt TG
Clin Chem; 1989 Mar; 35(3):431-4. PubMed ID: 2537688
[TBL] [Abstract][Full Text] [Related]
26. Cellular immunity and herpesvirus infections in cardiac-transplant patients.
Rand KH; Rasmussen LE; Pollard RB; Arvin A; Merigan TC
N Engl J Med; 1977 Jun; 296(24):1372-7. PubMed ID: 193008
[TBL] [Abstract][Full Text] [Related]
27. Cellular activation in the graft and in blood during CMV disease.
von Willebrand E; Lautenschlager I; Ahonen J
Transplant Proc; 1989 Feb; 21(1 Pt 2):2080-1. PubMed ID: 2540558
[No Abstract] [Full Text] [Related]
28. Influence of azathioprine and prednisone in vivo treatment on lymphocyte-dependent antibody-mediated cytotoxicity (LDAC) in 57 human renal allograft recipients.
Descamps B; Gagnon R; van Der Gaag R; Meyer O; Crosnier J
Transplant Proc; 1977 Mar; 9(1):981-4. PubMed ID: 325832
[No Abstract] [Full Text] [Related]
29. [Studies on the testing of cellular and humoral immune responses in patients with so-called complex glomerulonephritis].
Bürkle PA; Tönnesmann E; Schäfer B; Franz HE; Federlin K
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():837-9. PubMed ID: 148188
[No Abstract] [Full Text] [Related]
30. Renal transplantation and viral infections. IV. A survey of herpes simplex virus excretion in relation to cellular specific immunity and humoral immunity among renal transplant recipients.
Fortier B; Nicolas JC; Burguière AM; Huraux JM; Bricout F
Biomedicine; 1978 Dec; 28(6):328-32. PubMed ID: 371689
[TBL] [Abstract][Full Text] [Related]
31. Virus studies in the treatment of congenital cytomegalovirus infections by cytosine arabinoside.
Emödi G; Sartorius J; Just M; Rohner F; Bühler U
Helv Paediatr Acta; 1972 Dec; 27(6):557-64. PubMed ID: 4346254
[No Abstract] [Full Text] [Related]
32. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.
Dreikorn K; Doerr HW; Geursen RG
Scand J Urol Nephrol Suppl; 1985; 92():15-21. PubMed ID: 3008312
[TBL] [Abstract][Full Text] [Related]
33. A comparison of humoral and cellular immune response to antigenic stimulation in healthy children.
Golebiowska H; Kunicka A; Lambert I; Duros H
Boll Ist Sieroter Milan; 1974; 53(1):suppl:186. PubMed ID: 4850177
[No Abstract] [Full Text] [Related]
34. [Immunologic diagnosis of cytomegalovirus infections in patients after kidney transplantation].
Sedlácková E; Korcáková L; Honzáková E; Kulková H; Franková V; Hásková V
Cesk Epidemiol Mikrobiol Imunol; 1988 Nov; 37(6):350-3. PubMed ID: 2849513
[No Abstract] [Full Text] [Related]
35. The role of T cell immunity in infection with the herpes group viruses.
Finberg R; Hom R
Year Immunol; 1986; 2():267-78. PubMed ID: 3033947
[No Abstract] [Full Text] [Related]
36. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
Eichler C; Kaden J; May G
Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
[TBL] [Abstract][Full Text] [Related]
37. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
Cauda R; Citterio F; Tamburrini E; Pozzetto U; Tumbarello M; Castagneto M; Ortona L
Transplant Proc; 1988 Apr; 20(2 Suppl 2):186-9. PubMed ID: 2834839
[No Abstract] [Full Text] [Related]
38. Cytomegalovirus antibody production in renal transplant patients.
Nagington J
J Hyg (Lond); 1971 Dec; 69(4):645-60. PubMed ID: 4332511
[TBL] [Abstract][Full Text] [Related]
39. Antibody modulation of cellular reactivity post renal transplantation.
Garovoy MR; Phillips SM; Carpenter CB; Merrill JP
Transplant Proc; 1973 Mar; 5(1):129-32. PubMed ID: 4266650
[No Abstract] [Full Text] [Related]
40. Viral infections in kidney transplant patients immunosuppressed with cyclosporine.
Takahashi K; Yagisawa T; Teraoka S; Toma H; Agishi T; Ota K; Kobayashi S
Transplant Proc; 1987 Feb; 19(1 Pt 3):2142-9. PubMed ID: 3029916
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
